GA

George Anastassov

Incannex Healthcare Limited | Non-Executive Director
Dr Anastassov is responsible for APIRx commercial operations, strategic decision-making, and oversight of all clinical development assets. He is one of the developers of the first-in-the world cannabinoid-containing chewing gum-based delivery system among a number of other systems and formulations. Previously, he was CEO and co-founder of AXIM Biotechnologies, which achieved an all-time-high market capitalization of approximately US$1.2B.

Company and Role

Company
Title
Tenure
Since
IHL
IHL
Incannex Healthcare Limited
  • Non-Executive Director
2yrs, 10mthJun 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IHL
IHL
Incannex Healthcare Limited
30/06/2366,972,077N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IHL
IHL
Incannex Healthcare Limited
05/08/22
Issued
66,972,077$0.570$38,174,083As advised by the company